Application of the quality by design (QbD) approach to the development and validation of analytical methods for the quantification of Lumateperone Tosylate as the bulk drug and capsule dosage form by HPLC
Crossref DOI link: https://doi.org/10.1186/s43094-025-00779-6
Published Online: 2025-02-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bavadekar, Vasudha S. https://orcid.org/0000-0003-1984-0061
Joshi, Angha M.
Desai, Ujwala S.
Text and Data Mining valid from 2025-02-25
Version of Record valid from 2025-02-25
Article History
Received: 1 May 2024
Accepted: 7 February 2025
First Online: 25 February 2025
Declarations
:
: Not applicable.
: No competing interests to declare.